glp 1 or mounjaro GLP-1 Weight Loss Myths: What to Know About & Safety GLP-1 Agonists for Diabetes: Mounjaro

General discussion Because of the close inter-relationship of CKD and CV disease, recognizing these clinical entities and their prognostic effect is of great importance

Trends Endocrinol Metab 2010;21:707-13.ArticlePubMedPMC 106

A 2025 article from SHRM reports a notable increase in the average representation of GLP-1 drugs used for weight loss in total annual claims for employers, increasing from 8.9 percent in 2024 to 10.5 percent in 2025

A recent review by Gatto et al., published in May 2025, reached a similar conclusionsuggesting that GLP-1 receptor agonists may have a positive impact on musculoskeletal health